In clinical studies, a majority of patients on HUMIRA saw symptom relief and many achieved remission (few or no symptoms) at 4 weeks.
HUMIRA is not right for everyone. Only your doctor can decide if HUMIRA is right for you.
HUMIRA has helped many people notice a significant difference in their symptoms in about 4 weeks; however, individual results may vary. Patients who do not see results within 12 weeks should talk to their doctor.
HUMIRA is used in clinical trials for the treatment of adult Crohn’s for the first time*
HUMIRA is used in clinical trials for the treatment of ulcerative colitis (UC) for the
HUMIRA is approved in the US as a treatment for moderate to severe adult
HUMIRA is approved in the US as a treatment for moderate to severe ulcerative colitis
Over one million patients are currently being treated with HUMIRA worldwide.1‡
*First adult Crohn's clinical trial patient dosed in 2002. †First UC clinical trial patient dosed in 2006. ‡As of June 2016.
Reference: 1. Data on file, AbbVie Inc. IMS NPA and IMS NSP cumulative data as of June 2016.
Managing your treatment for a chronic condition can be overwhelming. HUMIRA Complete can help you:
HUMIRA Complete also offers you a personal Nurse Ambassador,§ whose first priority will be to help you start and stay on track with your treatment as prescribed.
§Nurse Ambassadors do not give medical advice and will direct you to your health care professional for any treatment-related questions, including further referrals.Learn More About HUMIRA Complete
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a TNF blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
Tell your doctor about all of your health conditions, including if you:
Also tell your doctor about all the medicines you take. You should not take HUMIRA with ORENCIA® (abatacept), KINERET® (anakinra), REMICADE® (infliximab), ENBREL® (etanercept), CIMZIA® (certolizumab pegol), or SIMPONI® (golimumab). Tell your doctor if you have ever used RITUXAN® (rituximab), IMURAN® (azathioprine), or PURINETHOL® (mercaptopurine, 6-MP).
HUMIRA can cause serious side effects, including:
Call your doctor or get medical care right away if you develop any of the above symptoms.
Common side effects of HUMIRA include injection site reactions (redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
HUMIRA is given by injection under the skin.
HUMIRA is a prescription medicine used:
HUMIRA is a prescription medicine used to reduce signs and symptoms, and to achieve and maintain clinical remission in adults with moderate to severe Crohn’s disease who have not responded well to conventional treatments. HUMIRA is also used to reduce signs and symptoms and achieve clinical remission in these adults who have also lost response to or are unable to tolerate infliximab.
Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. HUMIRA may increase the chance of getting lymphoma, including a rare kind, or other cancers. HUMIRA can cause serious side effects including hepatitis B infection in carriers of the virus, allergic reactions, nervous system problems, blood problems, heart failure, certain immune reactions including a lupus-like syndrome, liver problems, and new or worsening psoriasis.